Treace Medical Concepts (TMCI) Competitors $7.19 +0.15 (+2.13%) Closing price 09/18/2025 04:00 PM EasternExtended Trading$7.20 +0.00 (+0.07%) As of 09/18/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TMCI vs. CNMD, NVCR, SSII, CDRE, BLFS, ESTA, MDXG, PLSE, INMD, and IRMDShould you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include CONMED (CNMD), NovoCure (NVCR), SS Innovations International (SSII), Cadre (CDRE), BioLife Solutions (BLFS), Establishment Labs (ESTA), MiMedx Group (MDXG), Pulse Biosciences (PLSE), InMode (INMD), and iRadimed (IRMD). These companies are all part of the "medical equipment" industry. Treace Medical Concepts vs. Its Competitors CONMED NovoCure SS Innovations International Cadre BioLife Solutions Establishment Labs MiMedx Group Pulse Biosciences InMode iRadimed CONMED (NYSE:CNMD) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, media sentiment, analyst recommendations, earnings, risk and institutional ownership. Do insiders & institutionals hold more shares of CNMD or TMCI? 84.1% of Treace Medical Concepts shares are owned by institutional investors. 3.1% of CONMED shares are owned by company insiders. Comparatively, 27.7% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts recommend CNMD or TMCI? CONMED currently has a consensus target price of $59.80, suggesting a potential upside of 16.16%. Treace Medical Concepts has a consensus target price of $9.83, suggesting a potential upside of 36.76%. Given Treace Medical Concepts' stronger consensus rating and higher possible upside, analysts plainly believe Treace Medical Concepts is more favorable than CONMED.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CONMED 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20Treace Medical Concepts 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the media prefer CNMD or TMCI? In the previous week, CONMED had 6 more articles in the media than Treace Medical Concepts. MarketBeat recorded 7 mentions for CONMED and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 1.87 beat CONMED's score of 0.59 indicating that Treace Medical Concepts is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is CNMD or TMCI more profitable? CONMED has a net margin of 8.31% compared to Treace Medical Concepts' net margin of -23.01%. CONMED's return on equity of 14.43% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets CONMED8.31% 14.43% 6.05% Treace Medical Concepts -23.01%-46.76%-23.35% Which has more risk & volatility, CNMD or TMCI? CONMED has a beta of 1.18, indicating that its share price is 18% more volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500. Which has stronger earnings & valuation, CNMD or TMCI? CONMED has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCONMED$1.31B1.22$132.42M$3.5314.58Treace Medical Concepts$209.36M2.17-$55.74M-$0.79-9.10 SummaryCONMED beats Treace Medical Concepts on 9 of the 16 factors compared between the two stocks. Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMCI vs. The Competition Export to ExcelMetricTreace Medical ConceptsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$444.74M$6.81B$5.76B$10.28BDividend YieldN/A1.21%5.74%4.63%P/E Ratio-9.1027.0876.8626.97Price / Sales2.17198.85543.77128.80Price / CashN/A21.6337.1760.63Price / Book3.975.0313.836.37Net Income-$55.74M$178.07M$3.29B$271.46M7 Day Performance-3.36%5.59%0.93%2.35%1 Month Performance2.13%8.50%5.31%7.78%1 Year Performance31.20%19.34%84.25%32.27% Treace Medical Concepts Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMCITreace Medical Concepts2.7533 of 5 stars$7.19+2.1%$9.83+36.8%+31.2%$444.74M$209.36M-9.10250Positive NewsCNMDCONMED4.342 of 5 stars$53.78-2.2%$59.80+11.2%-32.3%$1.70B$1.31B15.233,900Ex-DividendInsider TradeNVCRNovoCure4.2546 of 5 stars$12.60+2.6%$28.79+128.5%-26.2%$1.37B$605.22M-8.081,488Positive NewsGap UpSSIISS Innovations InternationalN/A$6.14-12.3%N/AN/A$1.36B$20.65M0.004News CoverageGap UpHigh Trading VolumeCDRECadre2.5708 of 5 stars$31.83-0.5%$31.50-1.0%-6.0%$1.30B$567.56M33.862,284Positive NewsBLFSBioLife Solutions2.5265 of 5 stars$26.22-0.9%$31.29+19.3%+10.8%$1.27B$93.47M-218.48440Positive NewsESTAEstablishment Labs2.4696 of 5 stars$38.24-2.0%$56.50+47.8%-4.2%$1.13B$166.02M-12.541,018Positive NewsMDXGMiMedx Group3.5235 of 5 stars$7.17+0.4%$12.00+67.4%+15.7%$1.06B$348.88M34.14870Positive NewsPLSEPulse Biosciences4.1305 of 5 stars$15.04-0.5%$22.00+46.3%-2.4%$1.02B$700K-14.32140News CoveragePositive NewsInsider TradeGap UpINMDInMode2.9574 of 5 stars$15.28+2.0%$18.04+18.1%-13.1%$946.87M$401.56M6.19480Positive NewsIRMDiRadimed4.7948 of 5 stars$71.85-0.2%$72.00+0.2%+49.4%$915.36M$73.24M44.35110News CoveragePositive NewsInsider TradeShort Interest ↓ Related Companies and Tools Related Companies CONMED Alternatives NovoCure Alternatives SS Innovations International Alternatives Cadre Alternatives BioLife Solutions Alternatives Establishment Labs Alternatives MiMedx Group Alternatives Pulse Biosciences Alternatives InMode Alternatives iRadimed Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TMCI) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
